Abigail Lea Fabbrini

Abigail Lea Fabbrini

Auto-generated profile, based on publicly available information

Abigail Lea Fabbrini

Office of Medical Education, College of Osteopathic Medicine, Kansas City University, Kansas City, MO, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Pediatric Gastroenterology, Hepatology & Nutrition
Verified
Journal Article
Open access
JBJerry Mack Brown
Jerry Mack Brown
MKMolly Kidder
Molly Kidder
AFAbigail Fabbrini
Abigail Fabbrini
JDJonathan Devries
Jonathan Devries
JRJason Robertson
Jason Robertson
MWMichael J. Wilsey
Michael J. Wilsey
We report the case of a seven-year-old boy with an ingested foreign body, which was retained within the appendix for a known duration of ten months, ultimately requiring appendectomy. The ingested foreign body was incidentally discovered by abdominal x-ray at an emergency room visit for constipation. Despite four bowel cleanouts, subsequent x-rays showed persistence of the foreign body in the right lower quadrant. While the patient did not have signs or symptoms of acute appendicitis, laparoscopic appendectomy was performed due to the risk of this foreign body causing appendicitis in the future. A small metallic object was found within the appendix upon removal. This case highlights the unique challenge presented by foreign body ingestions in non-verbal or developmentally challenged children and the importance of further diagnostic workup when concerns arise for potential retained foreign bodies.

10 March 2024 in Clinical Pediatrics
Verified
Journal Article
Closed access
JBJerry Mack Brown
Jerry Mack Brown
JBJessica V. Baran
Jessica V. Baran
LLLuke Lamos
Luke Lamos
JBJesse Beacker
Jesse Beacker
JFJared Florio
Jared Florio
MWMichael John Wilsey
Michael John Wilsey
Cow’s milk protein allergy (CMPA) affects 2% to 3% of infants and is managed with hypoallergenic formulas. The 2022 recalls of infant formulas due to factors including contamination led to specialty formula shortages, highlighting CMPA management challenges. Understanding health care providers’ (HCPs) decision-making in transitioning to alternative formulas during shortages is crucial. Limited attention has been given to how pediatric physicians make these choices. This study utilized US HCPs’ de-identified survey data to assess driving factors when switching extensively hydrolyzed formulas during shortages. A total of 104 eligible HCPs participated, including general pediatrics, pediatric allergy/immunology, and pediatric gastroenterology specialists. Safety, tolerability, and efficacy were identified as top factors for switching formulas. Formula 1 was considered well-tolerated, patient-accepted, and safe by all HCPs. Most expressed strong belief in Formula 1’s safety and effectiveness. Findings inform CMPA management during shortages, offering guidance to HCPs for suitable formula selection and enhanced infant care.